LipidDoc’s Daily is out !
Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg
Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg
Though the reasons aren’t clear, drops in estrogen likely play a significant role in accelerating plaque, says Matthew Budoff.
New indications supported by CLEAR Outcomes trial
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with the prevalence of approximately 30%.1 The prevalence goes up among specific high-risk populations:…
New indication for patients with obesity or overweight and a history of cardiovascular disease
New indication for patients with obesity or overweight and a history of cardiovascular disease
Author links open overlay panel Christie M. Ballantyne MD a, Anandita Agarwala MD
Author links open overlay panel Christie M. Ballantyne MD a, Anandita Agarwala MD
Alcohol use, exercise habits, nutrition—many patients are misrepresenting their health histories to their doctors. Linda Wells asks: Why?
Users with access to atnyulmc.org should login with their NYU Langone Credentials. Users with access to home.nyu.edu should login with their NYU Credentials. Still have…
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced top-line results from the Phase 3 AEGIS-II trial evaluating the efficacy and safety of CSL112 (apolipoprotein A-I…